Latest / Morning Medical with Dr. Chow / Hantavirus in Netherlands, World Cup Health Plans, and Ensitrelvir Developments

Transcript

Hantavirus in Netherlands, World Cup Health Plans, and Ensitrelvir Developments · Morning Medical with Dr. Chow

• 0:00
  Welcome to Morning Medical with Doctor Chow.
• 0:02
  I'm Doctor Chi-Ming Chow, your host for today.
• 0:04
  As always, we're diving into the latest happenings in the world of health and medicine.
• 0:09
  Today, we're focusing on a concerning development involving the hantavirus, which has
• 0:14
  recently led to a quarantine of hospital staff in the Netherlands.
• 0:20
  A Dutch hospital, Radboud University Medical Center in Nijmegen, has placed twelve of its
• 0:26
  staff into a six-week preventive quarantine following a breach in protocol.
• 0:31
  This breach involved a patient who was infected with the hantavirus, a rare and potentially
• 0:38
  deadly virus.
• 0:39
  The patient was tied to an outbreak aboard the luxury cruise ship, MV Hondius.
• 0:45
  The breach occurred when the patient's blood and urine were not handled using the strictest
• 0:50
  international protocols required for this specific hantavirus strain.
• 0:55
  Although the chance of infection is considered small, the hospital decided to take
• 0:59
  precautionary measures to ensure the safety of its staff and prevent any potential spread.
• 1:06
  Dutch Health Minister Sophie Hermans reassured Parliament that, despite the breach, the
• 1:11
  procedures followed were still quite strict.
• 1:14
  However, they were not the strictest ones applicable for this particular hantavirus case.
• 1:20
  The hospital expressed regret over the incident and is committed to analyzing the events to
• 1:24
  prevent future occurrences.
• 1:26
  They also emphasized their dedication to supporting the quarantined staff.
• 1:32
  This incident marks a significant shift from the hospital's earlier statements, which
• 1:36
  assured that appropriate isolation measures were in place.
• 1:39
  As of now, there have been eleven reported hantavirus cases, including three deaths.
• 1:46
  The World Health Organization has noted that, while the virus can be deadly, it poses a low
• 1:51
  risk to the general public.
• 1:54
  Health officials from cities across the United States are gearing up for the 2026 FIFA World
• 2:00
  Cup, anticipating a range of health challenges as millions of fans, many traveling from
• 2:06
  overseas, descend upon the country.
• 2:09
  These preparations are crucial as the expected influx of between five to seven million soccer
• 2:14
  fans will be spread across eleven host cities: Atlanta, Boston, Dallas, Houston, Kansas City,
• 2:22
  Los Angeles, Miami, New York City (partnered with East Rutherford, New Jersey),
• 2:28
  Philadelphia, the San Francisco Bay Area, and Seattle.
• 2:32
  The newly formed Big Cities Health Coalition, which consists of health officials from
• 2:37
  thirty-six of the nation’s largest health departments, is actively developing strategies
• 2:41
  to mitigate potential health risks associated with such a massive gathering.
• 2:46
  During a recent news briefing, health officials from several cities, including Atlanta, Dallas,
• 2:51
  New York City, Philadelphia, and San Jose, shared insights into their plans for monitoring
• 2:58
  diseases and conducting contact tracing during the soccer matches, which are set to kick off
• 3:03
  on June 11.
• 3:05
  While the hantavirus is not a major concern due to its rarity, officials are particularly
• 3:12
  worried about the spread of measles, given recent outbreaks across the country.
• 3:17
  Marcus Plescia, district health director at the Fulton County Board of Health in Atlanta,
• 3:24
  highlighted the complexities of tracking potential exposures.
• 3:29
  "Someone might be here for a game in Atlanta and be exposed to something like measles,"
• 3:33
  Plescia explained, "but by the time we realize that and start to look at who might be at risk,
• 3:39
  that fan could have traveled to Dallas to see their team play there."
• 3:44
  Alister Martin, commissioner of New York City’s health and mental hygiene department, also
• 3:48
  raised concerns about extreme heat, alcohol and drug use, and sexually transmitted diseases.
• 3:55
  He noted that relevant teams, ranging from disease control to mental health, have been
• 4:00
  preparing to work in new capacities for months.
• 4:02
  Recently, they tested their emergency capacity at healthcare facilities to ensure readiness.
• 4:08
  A significant challenge that these health officials face is the lack of resources, a
• 4:13
  consequence of the expiration of public health funding that was available during the COVID-19
• 4:18
  pandemic.
• 4:19
  Although host cities have received federal funding for security and infrastructure needs,
• 4:24
  public health services have not seen similar financial support.
• 4:29
  "In Atlanta, at least, there’s been some significant investment in infrastructure
• 4:34
  improvements, and those are very important things," Plescia mentioned, "but we’ve not
• 4:39
  received a lot of direct funding for specific public health services."
• 4:45
  In recent developments, an antiviral medication called ensitrelvir has shown promising results
• 4:51
  in preventing household contacts from contracting COVID-19.
• 4:55
  This finding comes from a randomized trial that highlighted the effectiveness of ensitrelvir as
• 5:01
  a postexposure prophylaxis, or PEP, for those living with someone infected by the virus.
• 5:08
  The trial, led by Doctor Frederick Hayden from the University of Virginia, revealed that only
• 5:13
  2.9 percent of household contacts who took ensitrelvir developed COVID-19 within ten days.
• 5:20
  This is a significant reduction compared to the 9 percent who received a placebo.
• 5:25
  These results suggest that the risk of contracting COVID-19 from an infected household
• 5:30
  member could be more than halved by using this antiviral.
• 5:35
  The study's findings have been published in the New England Journal of Medicine, and the United
• 5:39
  States Food and Drug Administration is currently reviewing an application for the use
• 5:43
  of ensitrelvir as a COVID-19 PEP.
• 5:47
  A decision is expected in June, which could potentially pave the way for its use in broader
• 5:52
  settings beyond households, such as nursing homes and chronic care facilities.
• 5:58
  The phase three SCORPIO-PEP trial, conducted between June 2023 and September 2024, included
• 6:06
  2,387 household contacts from various countries, including the United States, Japan,
• 6:13
  and South Africa.
• 6:15
  Participants were aged twelve years or older and were exposed to index patients who
• 6:19
  developed COVID-19.
• 6:21
  They were enrolled within seventy-two hours of the index patient showing symptoms and were
• 6:25
  either given ensitrelvir or a placebo.
• 6:29
  Notably, the trial demonstrated that ensitrelvir reduced lab-confirmed COVID-19
• 6:35
  infections with or without symptoms from 21.5 percent in the placebo group to 14 percent in
• 6:43
  those who took at least one dose of the antiviral.
• 6:46
  Moreover, even among those who did contract COVID-19, those on ensitrelvir had lower viral
• 6:52
  loads than their placebo counterparts.
• 6:56
  The safety profile of ensitrelvir was comparable to that of the placebo, with similar
• 7:01
  rates of adverse events.
• 7:04
  Importantly, those taking ensitrelvir did not experience a distorted sense of taste or
• 7:09
  gastrointestinal side effects, issues that have been associated with other antivirals like
• 7:16
  nirmatrelvir-ritonavir.
• 7:17
  However, it's important to note that the study did not include pregnant women, and ensitrelvir
• 7:22
  is known to be a moderately strong cytochrome P450 3A inhibitor.
• 7:28
  This means there could be potential drug-drug interactions, which is an important
• 7:33
  consideration for prescribing this medication.
• 7:36
  While the trial did not account for practices like masking that could influence transmission
• 7:40
  rates, nor did it measure the impact of antiviral use by some index patients, these
• 7:45
  promising results could mark a significant step forward in our fight against COVID-19.
• 7:51
  As we wait for the Food and Drug Administration's decision, the potential for
• 7:55
  ensitrelvir to be approved as a preventive measure offers hope for more effective control
• 8:01
  of COVID-19 transmission in residential and care settings.
• 8:07
  In a rather intriguing development, a doctor aboard the cruise ship MV Hondius, which was
• 8:13
  recently at the center of a hantavirus outbreak, has raised questions about his own
• 8:18
  health status.
• 8:19
  Doctor Stephen Kornfeld, an oncologist from Oregon, is currently in isolation at the
• 8:25
  University of Nebraska Medical Center in Omaha.
• 8:28
  Doctor Kornfeld had tested faintly positive for the hantavirus, though he's been asymptomatic
• 8:34
  so far.
• 8:36
  Doctor Kornfeld described his experience aboard the ship during the outbreak to CNN.
• 8:41
  He mentioned experiencing flu-like symptoms back in early April, including night sweats,
• 8:47
  chills, mild respiratory symptoms, and a lot of fatigue.
• 8:52
  These symptoms cleared up after a few days, but he questioned whether these could have been
• 8:56
  early signs of hantavirus infection.
• 8:59
  As the tests for hantavirus are not straightforward, it remains uncertain if his
• 9:04
  illness was indeed due to the virus or something else entirely.
• 9:09
  The Centers for Disease Control and Prevention, along with other laboratories, are currently
• 9:14
  conducting further tests to confirm whether Doctor Kornfeld indeed has the hantavirus.
• 9:20
  He explained that his initial tests, conducted in the Netherlands, returned one negative
• 9:25
  result and one faintly positive result.
• 9:28
  This has led to his current isolation as a precautionary measure, given the potential for
• 9:33
  developing symptoms later.
• 9:36
  Despite the uncertainty, Doctor Kornfeld remains in good spirits and described his time
• 9:42
  in the biocontainment unit as 'a little weird' but manageable.
• 9:47
  He noted that the facility is highly secure, so even if he were to become symptomatic, there’s
• 9:52
  no risk of the virus spreading beyond the containment area.
• 9:57
  He also mentioned that his room resembles a typical hospital room but with added layers of
• 10:02
  biocontainment, such as multiple doors and clean rooms for medical staff to change
• 10:07
  protective gear.
• 10:09
  Interestingly, Doctor Kornfeld became the de facto medical provider on the ship after the
• 10:14
  onboard doctor fell ill.
• 10:16
  He had contact with two individuals who were sick, which he believes may have increased his
• 10:21
  risk of exposure.
• 10:22
  However, he emphasized that the idea of hantavirus transmission through casual or
• 10:27
  airborne contact remains speculative at this stage.
• 10:31
  As we close today's episode, it is clear that the situation with the hantavirus, particularly
• 10:36
  aboard the MV Hondius, raises significant questions about disease transmission and the
• 10:42
  complexity of diagnosing rare illnesses.
• 10:45
  We will continue to monitor these developments closely.
• 10:49
  Thank you for joining me on Morning Medical with Doctor Chow.
• 10:53
  Stay tuned for more updates in the world of health and medicine.
• 10:56
  Until next time, stay informed and stay healthy.